NEWSLETTER - Issue 95 - June 15, 2019

Treatment of ACL with alternative regimens with meglumine antimoniate: an old solution to an old problem, says Dr. Armando Schubach

In 2017, after three years of discussions, the MoH introduced IL-MA treatment in Brazil and adopted the technique developed at INI, with minor adaptations to PAHO's recommendations

WHO issues warning regarding falsified meglumine antimonials vials in Iran and Pakistan

Hantavirus: a pathology of low prevalence and high mortality

According to the World Health Organization (WHO), the mortality rate of this disease is 38% and there is no treatment, cure or vaccine for the infection

"BSTM Pro-Vaccines Brazil" will promote debate and information that support the valuation of preventive measures

The biggest threat is not the fear of vaccination, but the absence of fear of the disease. Data indicate that 4 to 6% of Brazilians do not believe in vaccination. And 20% of people hesitate to vaccinate

INTERVIEW

Uruguay was a country where human leishmaniasis did not exist, notes Dr. Yester Basmadjian

The rapid expansion to the south is evidently multifactorial, but clearly linked to vector expansion. Without a vector there is no active transmission of this parasite

Brazilian Society of Tropical Medicine
Center for Tropical Medicine - UnB
Hours:
Monday to Friday from 8am to 12pm and from 14pm to 18pm
sbmt@sbmt.org.br - PO Box 4356 - Room 43C - 70904-970
Brasilia - DF - Phone/Fax: (61) 3307-1154

Chief-editor:
Carlos Henrique Nery Costa

Assignment editors:
Alberto Novaes
André Siqueira
Guilherme Werneck
Mitermayer Galvão dos Reis

Journalism:
Denise de Quadros
MTb 8458 DRT/RS

Translation:
Pedro Costa

Graphics and diagramation:
Leandro Matos